Research Article
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Figure 3
Specific cytotoxicity exhibited by EpCAM-specific CAR-NK-92 cells against EpCAM-positive target cells. The cytotoxic activity of CAR-NK-92 and Ctrl-NK-92 cells against EpCAM-negative or EpCAM-positive cells was determined using a 4-hour lactate dehydrogenase (LDH) release assay in a dose-dependent manner. ; ; ; ns: not significant.
(a) |
(b) |
(c) |
(d) |
(e) |